Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™
January 14, 2021 16:15 ET
|
Relay Medical Corp.
Glow LifeTech has the exclusive rights for MyCell Technology™ in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC™, a COVID-19 Treatment Candidate with...
EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19
February 18, 2020 09:30 ET
|
EastGate Biotech Corp.
Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses WEST CALDWELL, NJ and TORONTO, ON, Feb. 18, 2020 (GLOBE...
EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus
January 30, 2020 09:00 ET
|
EastGate Biotech Corp.
WEST CALDWELL, NJ and TORONTO, ON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on innovative technological...